Literature DB >> 17616543

The thermoluminescence dose-response and other characteristics of the high-temperature TL in LiF:Mg,Ti (TLD-100).

Y S Horowitz1, L Oster, H Datz.   

Abstract

Various characteristics of the high-temperature thermoluminescence (HTTL) in the glow curve of LiF:Mg,Ti (TLD-100) are reviewed. The proposed applications of the HTTL to mixed-field radiation dosimetry are outlined with special emphasis on the question of the linearity/supralinearity of the HTTL dose-response at low dose levels from 2.5 to 250 mGy. Recent measurements of the HTTL dose-response using non-linear hot-gas heating and linear planchet heating are discussed in detail. It appears that a mild HTTL supralinearity of approximately 15-50% for each dose decade may be present, followed by an abrupt and rapid increase in the supralinearity >250 mGy. However, difficulty in the estimation of background and the great variability in the protocols of measurement do not allow a definitive conclusion. There is much work to be done in the areas of protocol standardisation, materials selection, methods of data analysis and especially the details of background behaviour, and subtraction before the HTTL can become a reliable dosimetric tool.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17616543     DOI: 10.1093/rpd/ncm241

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  3 in total

1.  Investigation of the ionisation density dependence of the glow curve characteristics of LIF:MG,TI (TLD-100).

Authors:  Y S Horowitz; A Horowitz; L Oster; S Marino; H Datz; M Margaliot
Journal:  Radiat Prot Dosimetry       Date:  2008-07-29       Impact factor: 0.972

2.  Dose optimization of total or partial skin electron irradiation by thermoluminescent dosimetry.

Authors:  Lars Schüttrumpf; Klement Neumaier; Cornelius Maihoefer; Maximilian Niyazi; Ute Ganswindt; Minglun Li; Peter Lang; Michael Reiner; Claus Belka; Stefanie Corradini
Journal:  Strahlenther Onkol       Date:  2018-01-19       Impact factor: 3.621

3.  Dose-Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy.

Authors:  Raffaele Liuzzi; Consiglia Piccolo; Vittoria D'Avino; Stefania Clemente; Caterina Oliviero; Laura Cella; Mariagabriella Pugliese
Journal:  Dose Response       Date:  2020-02-13       Impact factor: 2.658

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.